BPMC

Blueprint Medicines Corporation - Common Stock (BPMC)

About Blueprint Medicines Corporation - Common Stock (BPMC)

Blueprint Medicines Corp. is a precision therapy company, which engages in the provision of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Details

Daily high

$101.70

Daily low

$98.63

Price at open

$99.14

52 Week High

$121.90

52 Week Low

$73.04

Market cap

6.5B

Dividend yield

0.00%

Volume

353,002

Avg. volume

799,272

P/E ratio

-40.77

Blueprint Medicines Corporation - Common Stock News